Glaukos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
1,094
Employees1,094
Headquarters
Aliso Viejo, California
HeadquartersAliso Viejo, California
Founded
1998
Founded1998
Employees
1,094
Employees1,094

GKOS Key Statistics

Market cap
10.48B
Market cap10.48B
Price-Earnings ratio
-54.43
Price-Earnings ratio-54.43
Dividend yield
Dividend yield
Average volume
567.81K
Average volume567.81K
High today
$181.75
High today$181.75
Low today
$175.14
Low today$175.14
Open price
$177.66
Open price$177.66
Volume
568.56K
Volume568.56K
52 Week high
$191.62
52 Week high$191.62
52 Week low
$73.16
52 Week low$73.16

Stock Snapshot

Glaukos(GKOS) stock is priced at $177.47, giving the company a market capitalization of 10.48B. It carries a P/E multiple of -54.43.

During the trading session on 2026-09-06, Glaukos(GKOS) shares reached a daily high of $181.75 and a low of $175.14. At a current price of $177.47, the stock is +1.3% higher than the low and still -2.4% under the high.

Trading activity shows a volume of 568.56K, compared to an average daily volume of 567.81K.

Over the past 52 weeks, Glaukos(GKOS) stock has traded between a high of $191.62 and a low of $73.16.

Over the past 52 weeks, Glaukos(GKOS) stock has traded between a high of $191.62 and a low of $73.16.

GKOS News

Simply Wall St 4d
Chief Development Officer Of Glaukos Sold 28% Of Their Shares - simplywall.st

...

Chief Development Officer Of Glaukos Sold 28% Of Their Shares - simplywall.st
Simply Wall St 7d
Glaukos On The iDose TR Narrative And Why Valuation Still Draws Attention

Advertisement Glaukos stock performance snapshot after recent trading session Glaukos (GKOS) drew investor attention after its latest trading session, with th...

Glaukos On The iDose TR Narrative And Why Valuation Still Draws Attention

Analyst ratings

87%

of 15 ratings
Buy
86.7%
Hold
13.3%
Sell
0%

People also own

Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.